Meigococcal B Prevetio Tools for Your Practice
NAPNAP MeB Facts for HCPs Fast Facts Although ucommo, MeB is potetially fatal. 1 MeB symptoms progress quickly; death ca occur i 24 hours or less. MeB accouts for about 1/3 of all US meigococcal cases. 2, * The majority of cases occur i patiets who have bee previously healthy. 3 Sice 2013, several outbreaks of MeB have occurred at colleges ad uiversities. 4 Vacciatio ca help prevet MeB. 3, To help protect agaist the 5 vaccie-prevetable serogroups of meigococcal disease, 2 differet types of vaccies are eeded oe for MeACWY ad oe for MeB. 3 I cliical studies of MeB vaccies, the ature ad frequecy of solicited adverse reactios varied accordig to the vaccie admiistered. The most commoly reported solicited adverse evets i idividuals 10 through 25 years of age icluded pai at the ijectio site, myalgia, erythema, fatigue, iduratio, ausea, arthralgia, headache, ad chills. 5,6 MeB vaccies are typically covered o the state level by the Patiet Protectio ad Affordable Care Act, ad covered by the Vaccies for Childre Program (VFC). 7,8, Meigitis vaccies may ot protect all recipiets. Recommedatio The Advisory Committee o Immuizatio Practices (ACIP) recommeds that a MeB vaccie series may be admiistered to adolescets ad youg adults aged 16 23 years to provide shortterm protectio agaist most strais of serogroup B meigococcal disease. The preferred age for MeB vacciatio is 16 18 years (recommedatio Category B). 9 What is a Category B recommedatio? l Category B recommedatios are made for idividual cliical decisio-makig. 9 Why is MeB assiged Category B? 9 l The curret low prevalece of MeB, coupled with the fact that importat data for makig policy recommedatios for MeB vaccies are ot yet available, resulted i the ACIP cocludig that isufficiet evidece exists to make a routie public health recommedatio that all adolescets be vacciated agaist MeB. 9 Give the seriousess of meigococcal disease ad the availability of licesed vaccies, the ACIP agreed that sufficiet evidece exists to ecourage idividual cliical decisio-makig. 9 A editorial article i Pediatrics by Drs. Marshall ad Ta states, Idividual cliical decisiomakig caot occur if a patiet does ot kow about the vaccie ad the disease. 10 1) HCPs should have a coversatio with patiets. 2) Determie, with the patiet, if cliical actio is the best course. EMPOWER YOUR PATIENTS l By startig a coversatio with your adolescet patiets ad their parets, you ca help them make a iformed decisio about MeB vacciatio. *I patiets aged <1 to 65 years, from 2005-2014; N=867. MeB vaccies may ot protect agaist all MeB strais. 5 Coverage, codig, cost to patiet, reimbursemet amout for product, ad admiistratio fee will vary by payer, pla, patiet, professioal settig, or services redered, ad are subject to chage without otice. Cost to patiets may vary. Coverage ad reimbursemet decisios are made by idividual payers followig receipt of claims from providers. Providers must follow documetatio ad billig requiremets of payer.
NAPNAP MEMBER Tips for Talkig to Your Patiets about Meigitis ad Vacciatio to HELP Protect Agaist It Preset vaccies with cofidece do t aticipate or expect a argumet. Expect a yes. Durig well ad sick visits, iclude vaccie discussios ad ecourage vacciatio agaist MeB i appropriate patiets. If questioed or challeged about vaccies, explai that meigitis is cotagious ad how it spreads. Iclude discussio that adolescets are a high-risk group which is why we focus o vacciatio at this age. Although ucommo, meigitis ca progress rapidly ad death ca occur withi 24 hours. Up to 20% of patiets ca have log-term sequelae, such as deafess, amputatios, kidey failure, ad brai damage. If cost seems to be a deterret, let your patiets kow there are resources that ca help. Discuss with parets that most isurace compaies ad Medicaid cover the vaccies ad there is a atioal vaccie program (VFC) to cover cost if ecessary. If a adolescet tells you he or she hates shots, you ca remid them that: Most people do ot like shots; however, the ifectios you could get if you are ot immuized ca be much worse. As a experieced provider, share a past story of a patiet with meigitis. Share with patiets: You re ot doe if you get just oe ad iclude a explaatio that they eed to receive all recommeded doses to get the best protectio agaist meigitis. Brought to you by the Natioal Associatio of Pediatric Nurse Practitioers. Fuded by ad developed i collaboratio with GSK. Refereces: 1. Pelto SI. Meigococcal disease awareess: cliical ad epidemiological factors affectig prevetio ad maagemet i adolescets. J Adolesc Health. 2010;46:S9-S15. 2. Ceters for Disease Cotrol ad Prevetio. Active bacterial core surveillace report, emergig ifectios program etwork, Neisseria meigitidis, 2005-2014. http://www.cdc.gov/abcs/reports-fidigs/surv-reports.html. Updated May 17, 2017. Accessed February 1, 2018. 3. Meigococcal vaccies for pretees, tees. Ceters for Disease Cotrol ad Prevetio website. https:// www.cdc.gov/features/meigococcal/idex.html. Updated April 24, 2017. Accessed February 1, 2018. 4. Serogroup B meigococcal disease outbreaks o U.S. college campuses. Natioal Meigitis Associatio website. http://www.maus.org/disease-prevetio-iformatio/ serogroup-b-meigococcal-disease/outbreaks/. Accessed February 1, 2018. 5. Prescribig Iformatio for BEXSERO. 6. Prescribig Iformatio for TRUMENBA. 7. Advisory Committee o Immuizatio Practices Vaccies for Childre Program: Vaccies to prevet meigococcal disease. Resolutio No. 10/16-3. Ceters for Disease Cotrol ad Prevetio website. https://www.cdc.gov/vaccies/programs/vfc/dowloads/ resolutios/2016-10-3-meig.pdf. Effective October 19, 2016. Accessed February 1, 2018. 8. MacNeil JR, Rubi L, Folarami T, et al. Use of serogroup B meigococcal vaccies i adolescets ad youg adults: recommedatios of the Advisory Committee o Immuizatio Practices, 2015. MMWR. 2015;64(41):1171 1176. 9. US Departmet of Health & Huma Services. The Affordable Care Act ad immuizatio. Available at www.hhs.gov/healthcare/facts-ad-features/fact-sheets/aca-adimmuizatio/idex.html. Accessed February 1, 2018. 10. Marshall GS, Ta L. Uderstadig the Category B recommedatio for serogroup B meigococcal vaccie. Pediatrics. 2017;139(5):e20163484. All trademarks are the property of their respective owers. 2018 GSK group of compaies or its licesor. Prited i USA. 832717R0 February 2018
Is meigitis life-threateig? It ca be. Meigococcal meigitis is a rare but serious disease caused by bacteria called Neisseria meigitidis. It ca lead to a ifectio of the liig of the brai ad spial cord or to septicemia, which is a ifectio of the blood. Meigitis ca strike without warig ad progress quickly. MeigitisB.com Where do I go for more iformatio about Meigitis B? Talk to your child s healthcare professioal or pharmacist about Meigitis B vacciatio. For more iformatio, visit www.meigitisb.com Your child may ot be vacciated agaist Meigitis B, eve if they received a meigitis vacciatio whe they were youger. MeigitisB.com 2016 GSK group of compaies. All rights reserved. Prited i USA. 718801R1 July 2016
If my child had a meigitis vaccie whe they were youger, do they still eed a Meigitis B vaccie? a w c y b Most likely. Meigococcal group B disease, or Meigitis B, is ot the same meigitis that most childre are vacciated agaist as adolescets. There are 5 vaccieprevetable meigitis groups A, C, W, Y, ad B ad there are two differet vaccies that ca help protect your child agaist these 5 groups. Most likely, the meigitis vaccie that your child may have received as a adolescet oly helps to prevet agaist Meigitis A, C, W, ad Y. A vaccie for Meigitis B has oly bee available sice late 2014. Most likely, your child has t bee vacciated agaist Meigitis B, which makes up a third of all meigitis cases i the US. Have there bee outbreaks of Meigitis B? While outbreaks of Meigitis B are rare, they are very serious. Betwee 2013 ad 2015, there were four outbreaks of Meigitis B disease reported o US college campuses. These ultimately led to two deaths. 24hr Is it true that Meigitis B ca be fatal withi 24 hours? Potetially. Symptoms such as fever, headache, ad eck stiffess ca progress rapidly ad ca become serious ad possibly fatal. 10% to 15% of people ifected with meigococcal disease will die, sometimes withi 24 hours. 11% to 19% of survivors ca experiece log-term effects such as brai damage, hearig loss, loss of limbs, ad seizures. Why are youg adults specifically at risk for Meigitis B? Youg adults 16 23 years of age are at icreased risk sice they ofte live i close quarters or are i close cotact with each other, i places such as schools, college dormitories, or military barracks. As a result, the Ceters for Disease Cotrol ad Prevetio (CDC) says that the Meigitis B vacciatio may be admiistered to youg adults 16 23 years old, preferably 16 18 years old, to help protect agaist Meigitis B. The CDC also recommeds Meigitis B vacciatio for persos 10 years ad older i certai groups who are at icreased risk for Meigitis B disease. How does Meigitis B spread? The bacteria ca spread from perso to perso through close cotact (coughig, seezig, or kissig). Kissig Coughig & Seezig Close Quarters
2016 GSK group of compaies. All rights reserved. Prited i USA. 745231R1 August 2016
3 thigs adolescets ad their parets/caregivers should kow about HELPING TO PREVENT MENINGITIS B (MEN B) 1. There are 2 DIFFERENT TYPES OF vaccies to help protect agaist the 5 vaccie-prevetable groups of meigitis oe for ACWY, ad oe for B. 2. MeB ca spread through close cotact such as kissig, Coughig, or livig i close quarters. 3. For best protectio, more tha oe dose of a MeB vaccie is eeded. Meigitis vaccies may ot protect all recipiets. Parets ad healthcare professioals are a importat part of protectig adolescets from Meigitis B. Lear more at MeigitisB.com. Your child received his or her first MeB vaccie o: Retur to the office for ext MeB vaccie(s) o: It is importat to complete your MeB vacciatio series. Make your appoitmet(s) today to help protect your child from meigitis. DON T WAIT, VACCINATE! Brought to you by the Natioal Associatio of Pediatric Nurse Practitioers. Fuded by ad developed i collaboratio with GSK. 2018 GSK group of compaies or its licesor. Prited i USA. 832715R0 February 2018
Brought to you by the Natioal Associatio of Pediatric Nurse Practitioers. Fuded by ad developed i collaboratio with GSK. LEARN MORE: MeigitisB.com www.apap.org/meig-resources NAPNAP Natioal Office 5 Haover Square, Suite 1401 New York, NY 10004 Phoe: 917-746-8300 All trademarks are the property of their respective owers. 2018 GSK group of compaies or its licesor. Prited i USA. 832716R0 February 2018